Leukemia Home > Gleevec and Other Uses
Gleevec® (imatinib mesylate) is licensed to treat certain types of cancer, such as leukemia and GIST. It belongs to a group of chemotherapy medications called tyrosine kinase inhibitors, which means it blocks an enzyme that cancer cells need to grow. Other uses for Gleevec include the treatment of:
- Myelodysplastic syndrome (MDS) and myeloproliferative disease (MPD)
- Hypereosinophilic syndrome (HES) or chronic eosinophilic leukemia
- Aggressive systemic mastocytosis (ASM)
- Dermatofibrosarcoma protuberans (DFSP).
(Click Gleevec Uses for information on the other conditions this drug can treat, when it is prescribed, whether children can take it, and more.)